Mind Cure Health Inc. (MCURF) Research

Mind Cure Health Inc., founded in Vancouver, Canada, in 2020, is a life sciences firm dedicated to improving mental health and wellness. The company develops and commercializes innovative products across North America, concentrating its efforts on pioneering digital therapeutics technology and exploring psychedelic compounds. This strategic approach aims to significantly broaden the availability of scientifically validated and evidence-based mental health treatments. Key offerings include iSTRYM, a distinctive digital therapeutics software designed to optimize the healing process for both patients and clinicians at all stages of therapy. Mind Cure also provides PsyCollage, a bioinformatics platform that helps prioritize research endeavors, and produces synthetic ibogaine to support researchers and medical professionals. Additionally, the company is investigating various psychedelic compounds, suchibogaine, for potential applications in treating traumatic brain injuries and related disorders.

Market snapshot

Symbol
MCURF
Price
$0.51
Day change
+971.88%
Market cap
$122.6M
P/E ratio
-4.77x
52-week range
0.011-0.507
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Adocia S.A. (ADOIF)
  • Biostage, Inc. (BSTG)
  • Carmat S.A. (CKMTF)
  • Eupraxia Pharmaceuticals Inc. (EPRXF)
  • E-therapeutics Plc (ETXPF)
  • Herantis Pharma Oyj (HRPMF)
  • Karolinska Development AB (publ) (KDEVF)
  • Mindset Pharma Inc. (MSSTF)

Open Mind Cure Health Inc. (MCURF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.